Posts filtered by tags: Pharmaceutical[x]


 

Pfizer says its COVID-19 vaccine is safe and likely to work in younger children, and it's planning to ask for permission to use it in kids as young as 5

A group of kids elbow-bumping their tennis instructor after practice. Marko Geber/Getty Images Pfizer said its coronavirus vaccine is safe and likely to be effective in younger children. The pharmaceutical giant plans to soon apply for an expanded OK that includes 5- to 11-year-olds. The two-dose shot is already OK'd for people 12 years and older. See more stories on Insider's business page. The Pfizer-BioNTech coronavirus vaccine was safe and generated a promising immune response ...
Tags: Health, Science, News, US, Trends, Healthcare, Food And Drug Administration, Fda, Pfizer, Biotech, Pharmaceutical, Andrew Dunn, BioNtech, Albert Bourla, Coronavirus, COVID


The FDA's expert panel backs COVID-19 booster shots for adults 65 and older and those at highest risk of severe disease

The federal government has provided COVID-19 relief in numerous forms, from free vaccines to economic programs. Reuters An expert panel recommended that the FDA authorize booster shots for older and vulnerable adults. The doctors and health experts who advise the FDA say data suggests younger people are still well protected. The panel vote down a proposal to make boosters available to everyone 16 and older. See more stories on Insider's business page. An expert panel advising the Food...
Tags: Health, Science, News, Cdc, Kaiser Permanente, Israel, US, Trends, United States, Healthcare, Food And Drug Administration, Fda, Pfizer, Biotech, Biden, Committee


The COVID-19 booster debate is a mess. Here's why we'll probably get extra shots anyway.

President Joe Biden gets a COVID-19 vaccine. Demetrius Freeman/The Washington Post via Getty Images The US debate over booster shots has devolved into a confusing and noisy mess. The next week should bring clarity, with FDA and CDC reviews wrapping up. Boosters are justified for older adults, experts told Insider, but there's less data on younger people. See more stories on Insider's business page. The debate over COVID-19 booster shots in the US has devolved into a noisy, confu...
Tags: Health, Science, News, Washington Post, Cdc, Brown University, US, Trends, Joe Biden, Analysis, Healthcare, Delta, Food And Drug Administration, World Health Organization, Fda, Pfizer


A massive study from Israel suggests older adults were far less likely to develop severe COVID-19 after a booster shot, but the finding carries major limitations

An Israeli receives a coronavirus vaccine from medical staff at a COVID-19 vaccination center in Tel Aviv, Israel, Wednesday, Jan. 6, 2021. Sebastian Scheiner/AP A third dose of Pfizer's coronavirus vaccine dramatically reduces the risk of infection and severe illness for older adults, a new study found. A team of researchers in Israel published the findings Wednesday in The New England Journal of Medicine. Still, an expert urged caution on interpreting the findings, saying the study...
Tags: Health, Science, News, Israel, US, Trends, Healthcare, Food And Drug Administration, Fda, Pfizer, Biotech, Biden, Centers For Disease Control And Prevention, Murray, New England Journal of Medicine, Tel Aviv Israel


FDA releases documents outlining Pfizer's case for COVID-19 booster shots

Vials of the Pfizer-BioNTech Covid-19 vaccine. Patrick Fallon/AFP via Getty Images The FDA released documents Wednesday giving a look at Pfizer's case for COVID-19 booster shots. The data shows a third dose of Pfizer's shot raised antibody levels with no major safety concerns. An expert panel will make recommendations to the FDA on booster shots on Friday. See more stories on Insider's business page. The US Food and Drug Administration published documents on Wednesday that prov...
Tags: Health, UK, Science, News, Cdc, Trends, Healthcare, Delta, Fda, Pfizer, Biotech, Biden, Centers For Disease Control And Prevention, US Food and Drug Administration, Pharmaceutical, Andrew Dunn


Seqera Labs grabs $5.5M to help sequence Covid-19 variants and other complex data problems

Bringing order and understanding to unstructured information located across disparate silos has been one of more significant breakthroughs of the big data era, and today a European startup that has built a platform to help with this challenge specifically in the area of life sciences — and has, notably, been used by labs to sequence and so far identify two major Covid-19 variants — is announcing some funding to continue building out its tools to a wider set of use cases, and to expand into North...
Tags: Health, TC, Mark Zuckerberg, Europe, Science, Enterprise, Big Data, Funding, Articles, Tech, Barcelona, Ceo, Computing, Machine Learning, North America, Alpha


10 Pharmaceutical WordPress Themes

The accessibility of Pharmacy has been made possible through its widespread online availability. Having an online platform where you can let your potential customers purchase from your pharmacy will provide comfort and convenience for them. Consumers now don’t need to go through the difficulty of finding the nearest pharmacy as they can access it through their phones or computer. Despite the easy access, it is still important that the pharmacy provides a level of trust and also easy accessibilit...
Tags: Advertising, Features, Pharmaceutical, Blog Tips, Rehealth Medical, IPharm Online Pharmacy Medical WordPress, MediStore Medical WordPress Theme Works, GreenGrow Medical Marijuana, Medigroup Medical, PharmaCare Pharmacy and Medical Store


The leaders of the FDA and CDC are reportedly pushing back on Biden's booster-shot plan, saying they need more time and data

President Joe Biden speaks about prescription drug prices and his "Build Back Better" agenda from the East Room of the White House, Thursday, Aug. 12, 2021, in Washington. Associated Press/Evan Vucci The heads of the FDA and CDC are pushing back on the White House's plan for COVID-19 booster shots. The top health officials say they need more time to review data on extra doses, . It's the latest setback to the Biden administration's booster plan, which has also prompted resigna...
Tags: Health, Science, News, Cdc, White House, US, Trends, Joe Biden, Healthcare, The Times, Fda, Pfizer, Biotech, Biden, Times, Johnson Johnson


Pfizer's CEO tell us why he thinks we'll need COVID-19 vaccines every year, like flu shots

Albert Bourla, CEO of Pfizer Crystal Cox/Skye Gould/Insider People will most likely need annual COVID-19 booster shots, Pfizer CEO Albert Bourla told Insider. It's another sign that we'll be dealing with the novel coronavirus for years to come. The pharma exec highlighted the risk of new variants emerging and vaccine protection waning. See more stories on Insider's business page. Pfizer CEO Albert Bourla predicted in a Wednesday interview that people will most likely need annua...
Tags: Health, Science, News, US, Trends, Healthcare, Food And Drug Administration, World Health Organization, Fda, Pfizer, Pharmaceutical, Moderna, Andrew Dunn, Albert Bourla, Bourla, Hilary Brueck


EQRx has a bold strategy to disrupt biotech

Hollis Johnson/Business Insider Hello,Welcome to Insider Healthcare. I'm Shelby Livingston, and I cover how healthcare is paid for and delivered in the US for the Insider healthcare team. Today in healthcare news:EQRx plans to disrupt the drug industry with lower prices, but industry insiders question its strategy; The FDA fully approved Pfizer's COVID-19 vaccine, a move that could boost vaccinations;Here's what biopharma companies like Novartis and Pfizer pay their scientists,...
Tags: US, Trends, Healthcare, New Zealand, Food And Drug Administration, Fda, Novartis, Pfizer, Vaccine, Getty, Kaiser Health News, SPAC, Pharmaceutical, Newsletters, Moderna, Pete Bannan


Name in the news: Comirnaty

The U.S. Food and Drug Administration today granted full approval to the COVID-19 vaccine manufactured by Pfizer-BioNTech. The vaccine, which will be marketed as Comirnaty (generic name tozinameran), had been administered under an Emergency Use Authorization (EUA) since December 11, 2020; more than 200 million doses have been administered in the U.S. since that date. The Comirnaty name didn’t just appear out of the blue today. I mentioned it in a May 2021 column on vaccination terminology ...
Tags: Europe, US, Netflix, New York Times, Linguistics, Fda, Pfizer, Volvo, Ken, U S Food and Drug Administration, Spike, EUA, Pharmaceutical, Franken, Russ Meyer, John B


The pandemic created a bunch of biotech billionaires. Take our 5-question quiz to see how well you know the pay trends shaping the drug industry.

From left: Stephane Bancel of Moderna, Leonard Schleifer of Regeneron, and Stanley Erck of Novavax. Steven Ferdman/Getty Images; Adam Jeffery/CNBC/NBCU Photo Bank/NBCUniversal via Getty Images; Novavax; Skye Gould/Insider Several biotech executives became billionaires last year, as the pandemic drove vaccine sales and stock market fervor. How did that wealth trickle down through the industry? See if you can guess what executives and employees earned. This quiz is part of Insider's deep...
Tags: Science, News, Trends, Getty Images, Compensation, Healthcare, Pay Gap, Biotech, Sawyer, Pharmaceutical, Novavax, Regeneron, Skye Gould, Stanley Erck, Stéphane Bancel, Salary Data


Delta's surging and antibodies are waning: What to know about when we'll need COVID-19 booster shots

Moderna has soared over the past year on the back of its coronavirus vaccine. Radek Mica/Getty Images Should the US start offering people an extra COVID-19 vaccines dose? Supporters cite signs of waning protection and data suggesting a booster shot would help. Others say boosting now is unnecessary, because the shots still prevent hospitalizations and death. See more stories on Insider's business page. The debate over whether the US should roll out extra doses of coronavirus vaccines...
Tags: Health, Science, Cdc, France, Germany, Israel, Nbc News, US, Trends, Analysis, Healthcare, Delta, World Health Organization, Philadelphia, Fda, Pfizer


DPSRU Delhi Faculty Vacancy Recruitment 2021

Recruitment of Faculty Vacancy in DPSRU Delhi 2021 Online Application on prescribed proforma is invited for the following Sarkari Naukri Faculty vacancy posts in Delhi Pharmaceutical Sciences & Research University (DPSRU) on a regular basis. (Advertisement No. DPSRU/TEACHING/2021/01) There are many other Government Jobs available in Delhi, view all. DPSRU Faculty Vacancy 2021 - Table of ContentAbout DPSRU Delhi Faculty Recruitment 2021DPSRU Faculty Vacancies 2021Apply Online for... Please Cl...
Tags: Jobs, University, Delhi, Professor, Faculty, Pharmaceutical, Manisha, Associate Professor, Assistant Professor, Sarkari Naukri Faculty, DPSRU Delhi


Job Vacancy Recruitment in PMBI Delhi 2021

Job Vacancy Recruitment in PMBI Delhi 2021 Pharmaceuticals & Medical Devices Bureau of India (PMBI) invites applications from eligible candidates to fill up the following Sarkari Naukri vacancy posts on a contractual basis for a period of 03 years, extendable subject to satisfactory performance PMBI for the year 2021. (Advertisement No. 6/2021) ( = || []).push({}); About PMBDI Contract Job Vacancy Recruitment... Please Click on the Title to Read Full Detail...
Tags: Jobs, Mba, Manager, Delhi, Executive, Bureau, Pharmaceutical, Manisha, Sarkari Naukri, Temporary and Contract Govt. Job Vacancy, PMBI Delhi, PMBI


NDTL Scientist Vacancy Recruitment 2021

Scientist Vacancy Recruitment in NDTL 2021 National Dope Testing Laboratory (NDTL) is an Autonomous Body under the Ministry of Youth Affairs & Sports, Department of Sports, Government of India invites applications in the prescribed format from suitable Indian Nationals possessing excellent academic records and relevant work experience for recruitment and appointments to the following various Scientist Sarkari Naukri Vacancy posts on direct recruitment basis in NDTL.... Please Click on the Title ...
Tags: Jobs, Disaster, Chemical, Delhi, Scientist, Pharmaceutical, Manisha, Biological, Scientist Vacancy Recruitment, NDTL, NDTL 2021 National Dope Testing Laboratory NDTL


Men fill more than 9 in 10 biopharma CEO positions, an inequity that costs women more than $500 million in pay each year

Skye Gould/Insider Irene Jiang/Business Insider An Insider analysis of 182 biotech and pharma companies revealed that 92% of CEOs are men. The lack of diversity in the drug industry's CEO ranks costs women an estimated $532 million a year. Drug industry CEOs and other experts said equity is achievable if companies make it a priority. This article is part of a series called "The Cost of Inequity," examining the hurdles that marginalized and disenfranchised groups face acr...
Tags: Health, Science, Boston, Trends, Healthcare, Biotech, Gender Diversity, Bio, Anderson, Gilead Sciences, Cooke, Pharmaceutical, Brainard, Veracyte, Third Rock Ventures, Bonnie Anderson


Industrial cybersecurity startup Claroty raises $140M in pre-IPO funding round

Claroty, an industrial cybersecurity company that helps customers protect and manage their Internet of Things (IoT) and operational technology (OT) assets, has raised $140 million in its latest, and potentially last round of funding.   With the new round of Series D funding, co-led by Bessemer Venture and 40 North, the company has now amassed a total of $235 million. Additional strategic investors include LG and I Squared Capital’s ISQ Global InfraTech Fund, with all previous investors — Team8,...
Tags: Food, Startups, Internet Of Things, New York, Technology, Coca-cola, Funding, US, Articles, Tech, Ceo, United States, Computing, Pfizer, Lg, Siemens


Novavax says its coronavirus vaccine was 90% effective in a large trial, moving the shot a step closer to widespread use

lechatnoir/Getty Images Novavax said its coronavirus vaccine was 90% effective at preventing COVID-19. The shot succeeded in a study that enrolled almost 30,000 volunteers in the US and Mexico. The Maryland biotech plans to ask US regulators for permission to give the shot more widely. See more stories on Insider's business page. The biotech company Novavax said on Monday that its coronavirus vaccine succeeded in a final-stage clinical trial, demonstrating 90% efficacy at preventing...
Tags: Health, UK, Science, News, Maryland, Mexico, US, Trends, South Africa, Healthcare, Astrazeneca, Biotech, Johnson Johnson, Pharmaceutical, Novavax, Gaithersburg Maryland


3 lingering questions about COVID-19 vaccines will shape the pandemic's trajectory into 2022 and beyond

A medical assistant administers a COVID-19 vaccine dose to a woman at a clinic in Los Angeles on March 25, 2021. Mario Tama/Getty Images Coronavirus vaccines have been a stunning success story of the pandemic. But there are still a few key unanswered questions about the COVID-19 vaccines we have. Some of the biggest: How long does vaccine protection last, and how good will it be against new variants? See more stories on Insider's business page. Hot vax summer is here.More than half o...
Tags: Science, News, Cdc, India, New York City, US, Toronto, Los Angeles, Trends, South Africa, Healthcare, Poland, World Health Organization, Fda, University of Pennsylvania, Pfizer


Ada Health closes $90M Series B led by Leaps by Bayer

The digital health space continues cooking on gas: Berlin-based Ada Health has closed a $90M Series B round of funding led by Leaps by Bayer, the impact investment arm of the German multinational pharma giant, Bayer AG. Other investors in the round include Samsung Catalyst Fund, Vitruvian Partners, Inteligo Bank, F4 and Mutschler Ventures. The startup last raised around four years’ ago, reporting a $47M Series A round in 2017. But don’t be fooled by the low lettering of these rounds: Ada Health ...
Tags: Health, Google Play Store, TC, Europe, Cdc, Germany, Berlin, Digital, US, Samsung, Sutter Health, Kodak, Tech, Artificial Intelligence, Healthcare, Switzerland


Moderna says its coronavirus vaccine is effective in teens, and the biotech plans to apply in early June for an expanded OK

A coronavirus vaccine trial volunteer receives a shot. Glenn Asakawa/University of Colorado Moderna's coronavirus vaccine likely works in teens, according to study results that the biotech plans to submit to regulators next month. The vaccine could become the second OK'd for people as young as 12. Teens in Moderna's study had similar immune responses as adults who received the shot. See more stories on Insider's business page. Moderna's coronavirus vaccine appears to be...
Tags: Health, Science, News, Massachusetts, Trends, Healthcare, Pfizer, Biotech, US Food and Drug Administration, Pharmaceutical, Moderna, Andrew Dunn, Coronavirus, COVID, Coronavirus Vaccine, Dispensed


a smiling animal, with human teeth / Chat alors!

THE ORIGINAL? Aquafresh Toothpaste – 1998 Click image to enlarge Source : Adeevee, CDA Shortlist Agency : Grey Paris (France) LESS ORIGINAL Crest Toothpaste “unquestionable smiles” – 2021 Click image to enlarge Source : Agency : Publicis Conill Los Angeles (USA) [Author: Joe La Pompe]
Tags: Health, Advertising, Smile, Toothpaste, Animal, Smiling, Pharmaceutical, Print & Outdoor, Joe La Pompe, Animaux, Tooth, Sourire, Dentition, Dents, Dentifrice, Adeevee CDA Shortlist Agency


Sanofi and GlaxoSmithKline say their COVID-19 vaccine triggers a strong immune response, bolstering the late-comer program's potential as a booster shot

Sanofi CEO Paul Hudson Reuters Sanofi and GlaxoSmithKline said that their experimental COVID-19 vaccine succeeded in a mid-stage trial. The pharma giants plan to launch a pivotal-stage study with 35,000 volunteers in the coming weeks. The shot suffered from disappointing data and delays in 2020. The companies now hope for approval by year's end. See more stories on Insider's business page. One of the world's most closely watched coronavirus vaccine programs reported positive d...
Tags: Health, Science, Microsoft, US, Trends, Healthcare, GlaxoSmithKline, Johnson Johnson, Sanofi, GSK, Pharmaceutical, Andrew Dunn, Emma Walmsley, Coronavirus, Coronavirus Vaccine, Dispensed


dynamite sausages / Niveau originalité c’est un pétard mouillé?

THE ORIGINAL? NUT Childhood Obesity –  2019 “Your child cannot take that risk” Click the image to enlarge Source : Clube de Criaçao Agency : Criola, Natal (Brazil) LESS ORIGINAL Fundación PKU – 2021 “Protein kills us” Click the image to enlarge Source : Agency : VML Y&R Barcelona (Spain) [Author: Joe La Pompe]
Tags: Health, Social, Advertising, Environmental, Explosives, TNT, Non-profit, Sausage, Explosive, Barcelona Spain, Pharmaceutical, Sausages, Childhood Obesity, Print & Outdoor, Joe La Pompe, Clube de criacao Agency


Precipio extends 2-day gain to 404% following launch of the company's COVID-19 test on Amazon

Spencer Platt/Getty Images Precipio shares jumped by more than 400% during a rally that extended for a second day on Tuesday. The surge came after the company's COVID-19 antibody test started selling on Amazon. The 20-minute test was the first of its kind in the US to win FDA approval for emergency use. See more stories on Insider's business page. Precipio stock rocketed higher for a second session on Tuesday, with a fivefold surge in the price ignited after the specialty diagn...
Tags: Amazon, US, Trends, Markets, Food And Drug Administration, Stocks, Fda, Health Care, Pharmaceutical, Palo Alto California, Carla Mozee, Coronavirus, COVID, Antibody Test, COVID-19 test, MI Exclusive


Face mask or coffee cup? / Nescafé et refait!

THE ORIGINAL? Mucinex “Wear a mask” – August 2020 Click the image to enlarge Source : LittleBlackBook Agency : Mc Cann Health (USA) LESS ORIGINAL Nescafé “Stay healthy” – April 2021 Click the image to enlarge Source : BuenaPublicidad Agency : Circus Grey, Lima (Peru) [Author: Joe La Pompe]
Tags: Health, Social, Coffee, Advertising, Environmental, Beverages, Drink, Cafes, Drinking, Beverage, Espresso, Cafe, Non-profit, Mugs, LIMA Peru, Pharmaceutical


Word of the week: Bicycle Day

This is a big week in the altered-consciousness universe. Tuesday, April 20, is, of course, 4/20, the date “cherished by pot smokers around the world as a reason to toke up with friends and massive crowds each year,” as a 2019 Vox article put it. The holiday pays tribute to the afternoon hour, 4:20 p.m., when a group of stoners at San Rafael High School, in the San Francisco Bay Area, would gather in the early 1970s to get high. (The shift from time of day to calendar date works only in the U.S...
Tags: Holidays, Cannabis, Brooklyn, Linguistics, Vox, Basel, Los Angeles Times, San Francisco Bay Area, Pharmaceutical, Heidelberg Germany, Hofmann, Sandoz, Word of The Week, Nancy Friedman, Dominic Umile, San Rafael High School


Getting AstraZeneca's shot is safer than flying on a plane, experts say - the bigger problem is an 'explosion of vaccine skepticism'

French Health Minister Olivier Veran receives a dose of the AstraZeneca vaccine on the outskirts of Paris on February 8, 2021. THOMAS SAMSON/AFP via Getty Images Blood clots are a "very rare" side effect of AstraZeneca's shot, European regulators said Wednesday. But five medical experts told Insider they aren't convinced the shot actually causes clotting. Experts worry that public skepticism may unnecessarily derail AstraZeneca's global vaccine rollout. See more stories on Insi...
Tags: Health, UK, New York, Science, News, Massachusetts, US, Trends, Eu, Getty Images, Washington Dc, Paris, Healthcare, Brazil, World Health Organization, Astrazeneca


Pfizer's COVID-19 shot remains highly protective against the coronavirus, longer-term data shows

The arrival of coronavirus vaccines means people have started hawking so-called "vaccines" on the Dark Web. CHRIS JACKSON/POOL/AFP via Getty Images Pfizer released new data from a key study, showing lasting benefits for its COVID-19 vaccine. The two-dose vaccine was 91% effective at preventing symptomatic cases of COVID-19. Data from study volunteers in South Africa suggests the shot also fights concerning variants. See more stories on Insider's business page. Updated results from Pfiz...
Tags: Health, Science, News, US, Trends, South Africa, Healthcare, Astrazeneca, Pfizer, Oxford University, Biotech, Pharmaceutical, Chris Jackson, Reuters Pfizer, Centers for Disease Control and Prevention The, Andrew Dunn